Erratum: HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (Radiotherapy and Oncology (2014) 113 (317-323))

Fabian Lohaus, Annett Linge, Inge Tinhofer, Volker Budach, Eleni Gkika, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Melanie Avlar, Anca Ligia Grosu, Amir Abdollahi, Jürgen Debus, Christine Bayer, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, David Mönnich, Daniel Zips, Cläre Von Neubeck, Gustavo B. BarettonSteffen Löck, Howard D. Thames, Mechthild Krause, Michael Baumann

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Number of pages1
    JournalRadiotherapy and Oncology
    Volume114
    Issue number3
    DOIs
    StatePublished - Mar 1 2015

    ASJC Scopus subject areas

    • Hematology
    • Oncology
    • Radiology Nuclear Medicine and imaging

    Cite this

    Lohaus, F., Linge, A., Tinhofer, I., Budach, V., Gkika, E., Stuschke, M., Balermpas, P., Rödel, C., Avlar, M., Grosu, A. L., Abdollahi, A., Debus, J., Bayer, C., Belka, C., Pigorsch, S., Combs, S. E., Mönnich, D., Zips, D., Von Neubeck, C., ... Baumann, M. (2015). Erratum: HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (Radiotherapy and Oncology (2014) 113 (317-323)). Radiotherapy and Oncology, 114(3). https://doi.org/10.1016/j.radonc.2015.03.010